4CB-24195-16846
3 vaccinations
4 coded responses
37 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 076 / NJ
- Registered
- 2020-12-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-30
Registered in v-safe
-
2020-12-30
Dose 1 — Moderna
- 2020-12-30
-
2020-12-31
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-01-02
- 2021-01-03
- 2021-01-06
-
2021-01-13
Survey response — day 14, dose 1MedDRA: Back pain — Feeling: FairFree text: Upper back paonMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-20
-
2021-01-27
Dose 2 — Moderna
- 2021-01-27
-
2021-01-28
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to workAdult check-in
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
-
2021-02-10
Survey response — day 14, dose 2MedDRA: Upper respiratory tract infection — Feeling: Poor · Be unable to workFree text: Upper resp infectionMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-17
- 2021-02-24
- 2021-03-03
- 2021-03-10
- 2021-04-28
- 2021-07-28
-
2021-10-28
Dose 3 — Pfizer-BioNTech
-
2021-10-29
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: GoodFree text: Right supraclavicular lymphadenopathy painful and mobileMedDRA releases: 2024-11 · check-in free text available
- 2021-10-30
- 2021-10-31
- 2021-11-01
- 2021-11-02
- 2021-11-03
- 2021-11-04
- 2021-11-11
- 2021-11-18
- 2021-11-25
- 2021-12-02
- 2021-12-09
- 2022-01-29
-
2022-04-28
Survey response — 6 months, dose 3MedDRA: COVID-19 — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: CovidMedDRA releases: 2024-11 · check-in free text available
- 2022-10-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Moderna | |
| 2 | 2021-01-27 | Moderna | |
| 3 | 2021-10-28 | Pfizer-BioNTech | No |
Free text
Release 1 — day 14, dose 1
Symptoms: Upper back paon
Release 4 — day 14, dose 2
Symptoms: Upper resp infection
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Right supraclavicular lymphadenopathy painful and mobile
Release 11 — 6 months, dose 3
Symptoms: Covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Back pain | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Upper respiratory tract infection | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release